These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9298734

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M, Fowler WJ, Harper DR, Jeffries DJ, Layton GT.
    Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
    [Abstract] [Full Text] [Related]

  • 23. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA, Novelli VM, Keller PM, Ellis RW.
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ.
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [Abstract] [Full Text] [Related]

  • 26. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.
    Krause PR, Klinman DM.
    Nat Med; 2000 Apr; 6(4):451-4. PubMed ID: 10742154
    [Abstract] [Full Text] [Related]

  • 27. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR, Witkop CT, Webber BJ, Costello AA.
    Vaccine; 2017 Apr 25; 35(18):2351-2357. PubMed ID: 28359621
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD, Harper DR, Garcia-Valcarcel M, Fowler WJ, Aitken C, Jeffries DJ, Layton GT.
    J Med Virol; 1999 Sep 25; 59(1):78-83. PubMed ID: 10440812
    [Abstract] [Full Text] [Related]

  • 34. Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.
    LaRussa PS, Gershon AA, Steinberg SP, Chartrand SA.
    J Infect Dis; 1990 Sep 25; 162(3):627-33. PubMed ID: 2167335
    [Abstract] [Full Text] [Related]

  • 35. Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay.
    Cohen JI, Ali MA, Bayat A, Steinberg SP, Park H, Gershon AA, Burbelo PD.
    Clin Vaccine Immunol; 2014 Sep 25; 21(9):1288-91. PubMed ID: 24990909
    [Abstract] [Full Text] [Related]

  • 36. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
    Wittek AE, Arvin AM, Koropchak CM.
    J Clin Microbiol; 1983 Nov 25; 18(5):1146-9. PubMed ID: 6315766
    [Abstract] [Full Text] [Related]

  • 37. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.
    Choi UY, Huh DH, Kim JH, Kang JH.
    Hum Vaccin Immunother; 2016 Oct 02; 12(10):2560-2564. PubMed ID: 27484734
    [Abstract] [Full Text] [Related]

  • 38. Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response.
    Padilla JA, Grose C.
    Arch Virol Suppl; 2001 Oct 02; (17):27-39. PubMed ID: 11339548
    [Abstract] [Full Text] [Related]

  • 39. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC, Klein S, Baiker A, Wirth S, Sander M, Noelting C, Boecher O, Vizoso-Pinto MG.
    Pediatr Infect Dis J; 2012 Nov 02; 31(11):1148-52. PubMed ID: 22863912
    [Abstract] [Full Text] [Related]

  • 40. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G, Cereda PM, Cattaneo E, Achilli G, Gerna MT.
    J Infect Dis; 1979 Jul 02; 140(1):33-41. PubMed ID: 88490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.